ATE539351T1 - Verfahren zur schnellen beurteilung der schwere eines traumas - Google Patents

Verfahren zur schnellen beurteilung der schwere eines traumas

Info

Publication number
ATE539351T1
ATE539351T1 AT07722631T AT07722631T ATE539351T1 AT E539351 T1 ATE539351 T1 AT E539351T1 AT 07722631 T AT07722631 T AT 07722631T AT 07722631 T AT07722631 T AT 07722631T AT E539351 T1 ATE539351 T1 AT E539351T1
Authority
AT
Austria
Prior art keywords
severity
trauma
rapidly assessing
assessing
rapidly
Prior art date
Application number
AT07722631T
Other languages
English (en)
Inventor
Kristian Bangert
Lars Uttenthal
Original Assignee
Antibodyshop As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38421573&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE539351(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Antibodyshop As filed Critical Antibodyshop As
Application granted granted Critical
Publication of ATE539351T1 publication Critical patent/ATE539351T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/40—Disorders due to exposure to physical agents, e.g. heat disorders, motion sickness, radiation injuries, altitude sickness, decompression illness
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/42—Poisoning, e.g. from bites or stings
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
AT07722631T 2006-05-30 2007-05-30 Verfahren zur schnellen beurteilung der schwere eines traumas ATE539351T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80922806P 2006-05-30 2006-05-30
PCT/DK2007/000254 WO2007137584A1 (en) 2006-05-30 2007-05-30 Methods and devices for rapid assessment of severity of injury

Publications (1)

Publication Number Publication Date
ATE539351T1 true ATE539351T1 (de) 2012-01-15

Family

ID=38421573

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07722631T ATE539351T1 (de) 2006-05-30 2007-05-30 Verfahren zur schnellen beurteilung der schwere eines traumas

Country Status (6)

Country Link
US (4) US20090197280A1 (de)
EP (1) EP2035835B1 (de)
AT (1) ATE539351T1 (de)
ES (1) ES2379603T3 (de)
PL (1) PL2035835T3 (de)
WO (1) WO2007137584A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050272101A1 (en) * 2004-06-07 2005-12-08 Prasad Devarajan Method for the early detection of renal injury
US20070037232A1 (en) * 2005-03-31 2007-02-15 Barasch Jonathan M Detection of NGAL in chronic renal disease
PL2035835T3 (pl) 2006-05-30 2012-05-31 Antibodyshop As Sposoby szybkiej oceny ciężkości urazu
JP2010500535A (ja) * 2006-08-07 2010-01-07 アンチボディショップ・アクティーゼルスカブ 重大な腎損傷を除外するための診断検査
US8846036B2 (en) 2007-10-19 2014-09-30 Abbott Laboratories Antibodies that bind to mammalian NGAL and uses thereof
US7977110B2 (en) 2008-06-02 2011-07-12 Children's Hospital Medical Center Method for distinguishing between kidney dysfunctions
CN102759623A (zh) * 2012-07-06 2012-10-31 南京基蛋生物科技有限公司 一种检测ngal胶体金试纸条及其制备方法
WO2015006515A1 (en) * 2013-07-09 2015-01-15 Sri International Biomarker panel for dose assessment of radiation injury and micro plasma filter
KR101590622B1 (ko) * 2013-10-24 2016-02-01 (주)메디컬그룹베스티안 화상 중증도 판단 방법
JP6572078B2 (ja) * 2015-09-28 2019-09-04 富士フイルム株式会社 ピペットチップおよび液体注入方法

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3686081A (en) 1969-01-31 1972-08-22 Messerschmitt Boelkow Blohm Method for incorporating strength increasing filler materials in a matrix
IT1074038B (it) 1976-08-05 1985-04-17 Simes Esteri della epinina
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4357343A (en) 1981-06-26 1982-11-02 Baxter Travenol Laboratories, Inc. Nutritional composition for management of renal failure
US4502430A (en) 1982-11-08 1985-03-05 Ngk Spark Plug Co., Ltd. Ceramic heater
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
JP2912413B2 (ja) 1990-03-28 1999-06-28 東亜医用電子株式会社 粒度分布作成方法
US5273981A (en) 1990-10-18 1993-12-28 Monsanto Company Intramolecular carbamate derivative of 2,3-Di-O-blocked-1,4-dideoxy-4-fluoro-nojirimycins
US5405832A (en) 1991-11-27 1995-04-11 Immtech International Inc. Method of treating non-streptococcal bacterial infections
SE9401351D0 (sv) 1994-04-21 1994-04-21 Venge A method for diagnosis
US5552313A (en) 1994-11-21 1996-09-03 Kansas University DNA encoding mouse phosphotriesterase-related protein
AU698350B2 (en) * 1995-04-12 1998-10-29 Oy Medix Biochemica Ab Methods and test kits for diagnosis of periodontal diseases and for predicting the risk of progression thereof
US5750345A (en) 1995-10-31 1998-05-12 Evanston Hospital Corporation Detection of human α-thalassemia mutations and their use as predictors of blood-related disorders
US5627034A (en) 1995-12-05 1997-05-06 Wisconsin Alumni Research Foundation Assay for carcinoma proliferative status by measuring NGAL expression level
US6498142B1 (en) * 1996-05-06 2002-12-24 Curis, Inc. Morphogen treatment for chronic renal failure
NZ336467A (en) 1996-05-24 2000-10-27 Gen Hospital Corp Modulators of tissue regeneration using DNA enclding a kidney injury molecule KIM
AU8899298A (en) 1997-08-06 1999-03-01 Zymogenetics Inc. Lipocalin homologs
US6309888B1 (en) 1998-09-04 2001-10-30 Leuven Research & Development Vzw Detection and determination of the stages of coronary artery disease
AUPP784398A0 (en) 1998-12-21 1999-01-21 Monash University Kidney disease detection and treatment
AU5330200A (en) 1999-06-18 2001-01-09 Michigan State University Method and apparatus for the detection of volatile products in a sample
US6762032B1 (en) 1999-08-23 2004-07-13 Biocrystal, Ltd. Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response
EP1263464B1 (de) * 2000-03-09 2012-10-31 Genzyme Corporation Verwendung von antagonistischen anti-tgf-beta antikörpern zur behandlung oder zur vorbeugung von verlust an nierenfunktion
AU2001293964B2 (en) 2000-10-03 2007-06-14 Rowett Research Institute Method of assaying pyrrole-containing biological compounds
JP2004528814A (ja) 2000-10-13 2004-09-24 チルドレンズ メディカル センター コーポレーション 組織再構築関連状態についての非侵襲性酵素スクリーニング
US20040203083A1 (en) 2001-04-13 2004-10-14 Biosite, Inc. Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases
US7713705B2 (en) 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
DE60233301D1 (de) 2001-05-04 2009-09-24 Biosite Inc Diagnostische marker für akute herzerkrankungen und verfahren des gebrauchs
WO2003029462A1 (en) 2001-09-27 2003-04-10 Pieris Proteolab Ag Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
EP1300472A1 (de) 2001-10-02 2003-04-09 Stichting Top-Instituut Voedselwetenschappen Verfahren zur Prüfung der Wirkung von Nahrungsmittel, eine Resistenz gegen Kolonisation durch Bakterien zuerzeugen
US6767733B1 (en) * 2001-10-10 2004-07-27 Pritest, Inc. Portable biosensor apparatus with controlled flow
MY151199A (en) 2001-11-02 2014-04-30 Rigel Pharmaceuticals Inc Substituted diphenyl heterocycles useful for treating hcv infection
US20030119209A1 (en) * 2001-12-21 2003-06-26 Kaylor Rosann Marie Diagnostic methods and devices
US6986995B2 (en) 2002-02-28 2006-01-17 Prometheus Laboratories, Inc. Methods of diagnosing liver fibrosis
US6847451B2 (en) 2002-05-01 2005-01-25 Lifescan, Inc. Apparatuses and methods for analyte concentration determination
GB0215509D0 (en) 2002-07-04 2002-08-14 Novartis Ag Marker genes
US7056702B2 (en) 2002-12-16 2006-06-06 Kimberly Clark Co Detecting lipocalin
EP2360475B1 (de) 2003-03-27 2019-10-02 Children's Hospital Medical Center Verfahren und Kit zum Nachweis des Frühstadiums einer Nierentubuluszellenverletzung
US20050272101A1 (en) 2004-06-07 2005-12-08 Prasad Devarajan Method for the early detection of renal injury
US7776824B2 (en) * 2004-05-06 2010-08-17 The Trustees Of Columbia University NGAL for reduction and amelioration of ischemic and nephrotoxic injuries
CN101163971B (zh) * 2004-12-20 2013-03-20 免疫体公司 测定作为肾病诊断标记物的嗜中性粒细胞明胶酶相关性脂笼蛋白
US8454672B2 (en) 2005-02-11 2013-06-04 Arizant Healthcare Inc. Warming device for perioperative use
US20070037232A1 (en) 2005-03-31 2007-02-15 Barasch Jonathan M Detection of NGAL in chronic renal disease
WO2007023891A1 (ja) 2005-08-26 2007-03-01 Ccs Inc. 照明装置
WO2007044884A1 (en) 2005-10-11 2007-04-19 Dilithium Networks Pty Ltd. Methods and system for fast session establishment for h.324 and related telecommunications terminals
US20080090304A1 (en) 2006-10-13 2008-04-17 Barasch Jonathan Matthew Diagnosis and monitoring of chronic renal disease using ngal
AU2007217861A1 (en) 2006-02-17 2007-08-30 Children's Medical Center Corporation Free NGAL as a biomarker for cancer
PL2035835T3 (pl) 2006-05-30 2012-05-31 Antibodyshop As Sposoby szybkiej oceny ciężkości urazu
US20090123946A1 (en) 2007-10-19 2009-05-14 Abbott Laboratories Immunoassays and kits for the detection of ngal
US20090123970A1 (en) 2007-10-19 2009-05-14 Abbott Laboratories Glycosylated mammalian ngal and use thereof
US20090269777A1 (en) 2007-10-19 2009-10-29 Abbott Laboratories Immunoassays and kits for the detection of ngal
JP5848006B2 (ja) 2007-10-19 2016-01-27 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ Ｎｇａｌの検出用イムノアッセイ及びキット
US20090124022A1 (en) 2007-10-19 2009-05-14 Abbott Laboratories Antibodies that bind to mammalian ngal and uses thereof
WO2009059259A2 (en) 2007-10-31 2009-05-07 Children's Hospital Medical Center Detection of worsening renal disease in subjects with systemic lupus erythematosus
EP2362943A1 (de) 2008-11-21 2011-09-07 Phadia AB Verfahren, vorrichtungen und kits zum nachweis oder zur überwachung einer akuten nierenverletzung

Also Published As

Publication number Publication date
PL2035835T3 (pl) 2012-05-31
US9927446B2 (en) 2018-03-27
US20090197280A1 (en) 2009-08-06
US20180172710A1 (en) 2018-06-21
EP2035835B1 (de) 2011-12-28
ES2379603T3 (es) 2012-04-27
US20150064730A1 (en) 2015-03-05
US11125761B2 (en) 2021-09-21
EP2035835A1 (de) 2009-03-18
WO2007137584A1 (en) 2007-12-06
US20150323552A1 (en) 2015-11-12

Similar Documents

Publication Publication Date Title
ATE539351T1 (de) Verfahren zur schnellen beurteilung der schwere eines traumas
ATE554389T1 (de) Apex als marker für lungenkrebs
DE502006006367D1 (de) Verfahren zum messen einer analytkonzentration in
BRPI0915619A2 (pt) métodos para determinar uma probabilidade de que um sujeito tenha contribuído com material genético para amostra de teste de material genético, para caracterizar amostra de teste de material genético e para determinar se uma pessoa de interesse contribuiu com material genético para uma amostra de teste de material genético, kit para análise de amostra de teste de material genético e sistema para determinar se um sujeito contribuiu com material genético para uma amostra
DE602007000426D1 (de) Messvorrichtung und Verfahren zur Oberflächentexturmessung
FR2893711B1 (fr) Dispositif et procede de mesure capacitive par pont flottant
DE602006015521D1 (de) Messstreifen und verfahren für lateralfluss-testvorrichtungen
BR112013013460A2 (pt) métodos de identificação de um paciente com asma, método de monitoramento de um paciente com asma, uso de um kit de detecção de periostina total, kit de medição da periostina total, uso de um anticorpo anti-il-13, uso de uma quantidade terapeuticamente eficaz de lebrikizumab, uso de um inibidor da via de th2, método de avaliação de eventos adversos, anticorpo anti-periostina e teste de periostina total
DE502004002547D1 (de) Vorrichtung zum optischen Vermessen eines Objektes
MX2011009027A (es) Aparato y metodo para evaluar la salud vascular.
DE602007010886D1 (de) Vorrichtung zur Schätzung eines Indexes für Menschen und entsprechendes Verfahren
TW200739782A (en) Damage assessment of a wafer using optical metrology
BRPI0909260A2 (pt) Método de teste ultrassônico e equipamento para o mesmo
DE502006008992D1 (de) Verfahren zum bestimmen einer raumkoordinate eines messpunktes an einem messobjekt sowie entsprechendes koordinatenmessgerät
DE502005002548D1 (de) Verfahren und Vorrichtung zur interferometrischen Radarmessung
DE112009000078A5 (de) Verfahren und Vorrichtung zur Auswertung einer interferometrischen Messgröße
DE602007008027D1 (de) Ultraschalldiagnosevorrichtung und Verfahren zum Messen der Größe eines Zielobjekts
ATE506890T1 (de) Vorrichtung und verfahren zur vorhersage eines kontrollverlustes über einen muskel
WO2010097713A3 (en) Apparatus and method for assessing vascular health
BRPI0910030A2 (pt) método de teste ultra-sônico e equipamento para o mesmo.
DE102010018547A8 (de) Vorrichtung und Verfahren zum Messen eines Luftdrucks sowie System zum Erfassen von Luftdaten
BRPI0812226A2 (pt) dispositivo e método para o teste não destrutivo de objetos
AT9242U3 (de) Indizieranordnung und verfahren zur bestimmung eines motorkennwertes
AT10236U2 (de) Messanordnung und verfahren zur erfassung von messdaten
HK1136873A1 (en) Use of nnmt as a marker for lung cancer